Global Neuropsychiatric Drugs Market Assessment 2020 – Key players such as Sage Therapeutics, BlackThorn Therapeutics, H. Lundbeck A/S, Takeda, Cerevel Therapeutics, LLC, etc.

InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on “Global Neuropsychiatric Drugs Market Assessment – Revenue (US$ Mn) Forecast To 2028”

Request for Sample Pages: https://www.insightaceanalytic.com/report-details/global-neuropsychiatric-drugs-market-assessment/

According to the latest research by InsightAce Analytic, the global market for neuropsychiatric drugs is estimated to be valued at US$ XX million in 2020 and is expected to reach US$ XX million by 2028, with a remarkable CAGR of XX% from 2020 to 2028.

Neuropsychiatric disorders encompass a broad range of medical conditions that involve both neurology and psychiatry. Schizophrenia, major depression, and anxiety disorders are the major psychiatric diseases. The neuropsychiatric drug market is a well-established market with the availability of numerous drugs for treating different stages/phases of neuropsychiatric disorders.

The availability of novel therapeutic drugs for neuropsychiatric disease treatment, increased R&D investment by major pharmaceutical companies, and a rising number of individuals suffering from mental disorders are the major growth drivers of the global neuropsychiatric drug market. For instance, neuropsychiatric disorders are among the leading causes of disability in the US, followed by cardiovascular and circulatory diseases and neoplasms (Source: NIH). Around 4.7% of the adult population aged 18 and above regularly feel depressed. Additionally, in January 2020, a clinical-stage biopharmaceutical company BlackThorn Therapeutics focused on evolving targeted drugs for the treatment of central nervous system (CNS) disorders announced the progression of Phase 2 clinical trial for its, BTRX-335140 (BTRX-140), a selective antagonist for the kappa opioid receptor (KOR).

Market players such as Sage Therapeutics, BlackThorn Therapeutics, H. Lundbeck A/S, Takeda, Cerevel Therapeutics, LLC, etc. have various drugs in their pipeline for the treatment of neuropsychiatric disorders. The approval of these drugs in the market during the forecast period is expected to boost market growth significantly in the coming years.

Request for ToC/Proposal: https://www.insightaceanalytic.com/report-details/global-neuropsychiatric-drugs-market-assessment/

The Neuropsychiatric drugs market is fragmented with the presence of various players that operate in drug development for various disease indications and a strong presence in the local as well as international market.

Global neuropsychiatric drugs market report covers prominent players such as Novartis, Otsuka, Allergan, Eli Lilly, Sunovion, AstraZeneca, Actavis Laboratories, Johnson & Johnson, Bristol Myers, Sage Therapeutics, BlackThorn Therapeutics, H. Lundbeck A/S, Takeda, Cerevel Therapeutics, LLC among others.

Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/report-details/global-neuropsychiatric-drugs-market-assessment/

Market Segments
Global Neuropsychiatric Drugs Market Revenue (US$ Mn), By Type, 2018-2028
o Typical Antipsychotics
• Prochlorperazine
• Haloperidol
• Others
o Atypical Antipsychotics
• Aripiprazole
• Asenapine
• Cariprazine
• Clozapine
• Lurasidone
• Olanzapine
• Risperidone
• Others

Global Neuropsychiatric Drugs Market Revenue (US$ Mn), By Indication, 2018-2028
o Schizophrenia
o Bipolar Disorder
o Psychotic Depression
o Others

Global Neuropsychiatric Drugs Market Revenue (US$ Mn), By Route of Administration, 2018-2028
o Oral
o Parenteral

Global Neuropsychiatric Drugs Market Revenue (US$ Mn), By Region, 2018-2028
North America Neuropsychiatric Drugs Market Revenue (US$ Mn), By Country, 2018-2028
o U.S.
o Canada

Europe Neuropsychiatric Drugs Market Revenue (US$ Mn), By Country, 2018-2028
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
o Rest of Europe

Asia Pacific Neuropsychiatric Drugs Market Revenue (US$ Mn), 2018-2028
Latin America Neuropsychiatric Drugs Market Revenue (US$ Mn), 2018-2028
Middle East & Africa Neuropsychiatric Drugs Market Revenue (US$ Mn), 2018-2028

Why should buy this report:
To receive a comprehensive analysis of the growth prospects for the global neuropsychiatric drugs market
To receive industry overview and future trends in the neuropsychiatric drugs market
To analyze the major factors (drivers and restraints) influencing the growth of the neuropsychiatric drugs market
To get information on the neuropsychiatric drugs market size value/revenue (US$ Mn) forecast till 2028
To analyze the competitive developments such as major investments, mergers & acquisition in the neuropsychiatric drugs industry

For More Information @https://www.insightaceanalytic.com/report-details/global-neuropsychiatric-drugs-market-assessment/

InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.